The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Molecular Determinants of Dysregulated GABAergic Gene Expression in the Prefrontal Cortex of Subjects with Schizophrenia
Abstract
Background Prefrontal deficits in gamma-aminobutyric acid (GABA)ergic gene expression, including neuropeptide Y (NPY), somatostatin (SST), and parvalbumin (PV) messenger RNAs (mRNAs), have been reported for multiple schizophrenia cohorts. Preclinical models suggest that a subset of these GABAergic markers (NPY/SST) is regulated by brain-derived neurotrophic factor (BDNF), which in turn is under the inhibitory influence of small noncoding RNAs. However, it remains unclear if these mechanisms are important determinants for dysregulated NPY and SST expression in prefrontal cortex (PFC) of subjects with schizophrenia.Methods Using a postmortem case-control design, the association between BDNF protein, NPY/SST/PV mRNAs, and two BDNF-regulating microRNAs (miR-195 and miR-30a-5p) was determined in samples from the PFC of 20 schizophrenia and 20 control subjects. Complementary studies were conducted in cerebral cortex of mice subjected to antipsychotic treatment or a brain-specific ablation of the Bdnf gene.Results Subjects with schizophrenia showed deficits in NPY and PV mRNAs. Within-pair differences in BDNF protein levels showed strong positive correlations with NPY and SST and a robust inverse association with miR-195 levels, which in turn were not affected by antipsychotic treatment or genetic ablation of Bdnf.Conclusions Taken together, these results suggest that prefrontal deficits in a subset of GABAergic mRNAs, including NPY, are dependent on the regional supply of BDNF, which in turn is fine-tuned through a microRNA (miRNA)-mediated mechanism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It is also of note that common genetic risk for SCZ and BD also indicated shared pathways coalescing onto parvalbumin-positive interneurons, paralleling what has been among the most robust pathologic findings in SCZ and BD63,64.”
From Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders (2021) · cites this paper as [64]
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
(2008) · doi:10.1038/nrg2290 · Cited by 5,199
Prediction of Mammalian MicroRNA Targets
Lewis, B. P., Shih, I.-H., Jones-Rhoades, M. W., Bartel, D. P., & Burge, C. B. (2003) · Cell · doi:10.1016/s0092-8674(03)01018-3 · Cited by 5,199
Chen, X., Ba, Y., Ma, L., Cai, X., Yin, Y., Wang, K., Guo, J., Zhang, Y., Chen, J., Guo, X., et al. (2008) · Cell Research · doi:10.1038/cr.2008.282 · Cited by 4,560
Egan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888
Epigenetic regulation in psychiatric disorders
Tsankova, N., Renthal, W., Kumar, A., & Nestler, E. J. (2007) · Nature reviews. Neuroscience · doi:10.1038/nrn2132 · Cited by 1,400
Guidotti, A., Auta, J., Davis, J. M., Gerevini, V. D. G., Dwivedi, Y., Grayson, D. R., Impagnatiello, F., Pandey, G. N., Pesold, C., Sharma, R. P., et al. (2000) · Archives of General Psychiatry · doi:10.1001/archpsyc.57.11.1061 · Cited by 1,222
Allen, N. C., Bagade, S., McQueen, M. B., Ioannidis, J. P. A., Kavvoura, F. K., Khoury, M. J., Tanzi, R. E., & Bertram, L. (2008) · Nature Genetics · doi:10.1038/ng.171 · Cited by 1,054
High rates of schizophrenia in adults with velo-cardio-facial syndrome
Murphy, K. C., Jones, L. A., & Owen, M. J. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.10.940 · Cited by 1,024
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Self-citation
Cited by
Sorted by citations
Items 201–267 of 267
Medina, A. M., Hagenauer, M. H., Krolewski, D. M., Hughes, E., Forrester, L. C. T., Walsh, D. M., Waselus, M., Richardson, E., Turner, C. A., Sequeira, P. A., et al. (2023) · Translational Psychiatry · doi:10.1038/s41398-023-02418-1 · Cited by 9
Altered expression of schizophrenia-related genes in mice lacking mGlu5 receptors
Luoni, A., Gass, P., Brambilla, P., Ruggeri, M., Riva, M. A., & Inta, D. (2016) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-016-0728-z · Cited by 9
Ueno, H., Suemitsu, S., Murakami, S., Kitamura, N., Wani, K., Matsumoto, Y., Okamoto, M., & Ishihara, T. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1564081 · Cited by 9
Long-lasting changes in neural networks to compensate for altered nicotinic input
John, D., & Berg, D. K. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.020 · Cited by 9
Sawano, E., Iwatani, K., Tominaga‐Yoshino, K., Ogura, A., & Tashiro, T. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13274 · Cited by 8
Volk, D. W., & Lewis, D. A. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-410529-4.00105-4 · Cited by 11
Bian, Y., Kawabata, R., Enwright, J. F., Tsubomoto, M., Okuda, T., Kamikawa, K., Kimoto, S., Kikuchi, M., Lewis, D. A., & Hashimoto, T. (2024) · Psychiatry Research · doi:10.1016/j.psychres.2024.116084 · Cited by 7
Diagnostic value and role of serum miR-15a-5p in patients with schizophrenia
Xu, Z., Yang, R., Chen, G., & Jiang, M. (2024) · Annals of General Psychiatry · doi:10.1186/s12991-023-00489-4 · Cited by 6
Zaki, M. B., Abulsoud, A. I., Ashraf, A., Abdelmaksoud, N. M., Sallam, A.-A. M., Aly, S. H., El-Tokhy, F. S., Rashad, A. A., El‐Dakroury, W. A., Mageed, S. S. A., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155102 · Cited by 6
Fish, K. N., Rocco, B. R., Wilson, J. D., & Lewis, D. A. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.12.004 · Cited by 6
Gene expression profiling as functional readout of rodent models for psychiatric disorders
Molteni, R., Macchi, F., & Riva, M. A. (2013) · Cell and Tissue Research · doi:10.1007/s00441-013-1648-0 · Cited by 6
Erzın, G., Topçuoğlu, C., Bayram, Ş., Karadağ, H., Özkaya, G., Turhan, T., & Göka, E. (2019) · Psychiatry and Clinical Psychopharmacology · doi:10.1080/24750573.2019.1589175 · Cited by 5
Rezaei, S., Banasr, M., Prévot, T. D., Bansal, Y., Vieira, É. L. M., & Sibille, E. L. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1675003 · Cited by 4
Kotas, M., Stańczykiewicz, B., Sporniak, B., Pawlak, E., & Misiak, B. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106292 · Cited by 4
Okuda, T., Kimoto, S., Kawabata, R., Bian, Y., Tsubomoto, M., Okamura, K., Enwright, J. F., Kikuchi, M., Lewis, D. A., & Hashimoto, T. (2024) · Psychological Medicine · doi:10.1017/s0033291724002344 · Cited by 5
Hemby, S. E., & McIntosh, S. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1054506 · Cited by 5
Lin, C. C., Hung, Y. Y., & Huang, T. L. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000343 · Cited by 4
Yang, S.-S., He, Q., Gu, X., Liu, S., Ke, W., Chen, L., Li, B., Shu, Y., & Gao, W. (2025) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2025.100486 · Cited by 3
van Lier, B., Hierlemann, A. R., & Knoflach, F. (2018) · PeerJ · doi:10.7717/peerj.5543 · Cited by 3
Long-term adaptation of prefrontal circuits in a mouse model of NMDAR hypofunction
Ponserre, M., Ionescu, T. M., Franz, A. A., Deiana, S., Schuelert, N., Lamla, T., Williams, R. H., Wotjak, C. T., Hobson, S., Dine, J., et al. (2024) · Neuropharmacology · doi:10.1016/j.neuropharm.2024.109970 · Cited by 4
Cirino, M. L. A., Porsani, L. B., Neto, F. S. L., Tazima, M. F. G. S., Figueiredo, R. Z., Carlotti, C. G., Colli, B. O., Tirapelli, L. F., & Tirapelli, D. P. D. C. (2019) · Genetics and Molecular Research · doi:10.4238/gmr18213 · Cited by 3
Mapping of Nervous System Diseases via MicroRNAs
(2016) · CRC Press eBooks · doi:10.1201/b19229 · Cited by 3
Fin, N. A. S. H., Yip, A., Teo, L., Homman‐Ludiye, J., & Bourne, J. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.07.10.602904 · Cited by 3
Song, J., Xin, W., Yu, J., Zhao, Q., Li, H.-N., & Chen, D.-C. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1514475 · Cited by 2
Edmond, K. Z., & Matosin, N. (2025) · Neurobiology of Stress · doi:10.1016/j.ynstr.2025.100739 · Cited by 2
Khan, M. M., & Parikh, V. (2022) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527321666220401124151 · Cited by 2
Recent studies of the genetics of complex diseases associated with impaired cognitive functions
Бочарова, А. В., & Степанов, В. А. (2022) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2021-36-4-37-44 · Cited by 2
Epigenetic Regulation of GABAergic Targets in Psychiatry
Grayson, D. R., Kundaković, M., Chen, Y., Dong, E., & Guidotti, A. (2011) · Springer eBooks · doi:10.1007/978-3-642-17426-1_2 · Cited by 2
MicroRNA and gene expression profiling of response to lithium treatment for bipolar I disorder
Weng, J. T.-Y., Chi, Y.-X., Wu, L. S., Lee, C., & Cheng, A. T. A. (2015) · International Conference on Biomedical Engineering and Informatics (BMEI) · doi:10.1109/bmei.2015.7401546 · Cited by 2
The Role of microRNA in the Pathogenesis of Schizophrenia
Ghasemzadeh, Z., khanjani-Jelodar, S., Nazari-Serenjeh, F., & Ghadikolaii, N. L. (2022) · The Neuroscience Journal of Shefaye Khatam · doi:10.52547/shefa.11.1.119 · Cited by 2
Sánchez-Florentino, Z. A., Romero-Martínez, B. S., Flores‐Soto, E., Serrano, H., Montaño, L., Valdés‐Tovar, M., Calixto, E., Aquino‐Gálvez, A., López-Riquelme, G. O., Alvarado, R., et al. (2023) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2023.5331 · Cited by 2
Greenberg, Z., Ramshaw, H. S., & Schwarz, Q. (2015) · AIMS neuroscience · doi:10.3934/neuroscience.2015.4.294 · Cited by 4
Tripp, A. C., Kota, R. S., Lewis, D. A., & Sibille, E. L. (2010) · Cited by 2
Medina, A., Hagenauer, M. H., Krolewski, D. M., Hughes, E., Forrester, L. C. T., Walsh, D. M. A., Waselus, M., Richardson, E., Turner, C. A., Sequeira, A., et al. (2022) · medRxiv · doi:10.1101/2022.06.03.22275600 · Cited by 2
MicroRNAs in metabolic effects with atypical antipsychotics—a scoping review
Wu, W. T., Setiawan, D., Glatt, S. J., Chi, J., & Lin, P. (2026) · Therapeutic Advances in Psychopharmacology · doi:10.1177/20451253261430603 · Cited by 1
MicroRNA Implications in Neurodegenerative Disorders
Chaudhuri, A. D., & Yelamanchili, S. V. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_21 · Cited by 1
Association between neuropeptide Y gene polymorphism and antipsychotics effect
Zhang, Q. Y., Wan, Y., Du, X., Gao, Y., Wang, X., Wu, K., Zheng, X., Wang, Y., Zhao, C., Li, L., et al. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.1014952 · Cited by 1
Schmitt, A., Popovic, D., Raabe, F. J., Papiol, S., Martins‐de‐Souza, D., & Falkai, P. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_46-1 · Cited by 1
miRNA Dysregulation in Schizophrenia
Kaleem, M., Fule, R. A., Alhosin, M., Danao, K. R., Mendhi, S. M., Mahajan, U., Ahmad, W., Dumore, N. G., Abdul, W. M., & Godbole, M. D. (2024) · Springer eBooks · doi:10.1007/978-981-99-9404-5_6 · Cited by 1
Oriaifo, S. E. (2015) · International Research Journal of Medicine and Medical Sciences · doi:10.14303/jmms.2015.116 · Cited by 1
miRNAs and Neurodevelopmental Disorders
Lin, Q., & Sun, Y. E. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-391494-1.00009-4 · Cited by 1
Lutgen, V. (2012) · e-Publications@Marquette (Marquette University) · Cited by 1
Rocco, B. R. (2015) · D-Scholarship@Pitt (University of Pittsburgh)
DEVELOPMENT OF CORTICAL GABA CIRCUITRY: IDENTIFYING PERIODS OF VULNERABILITY TO SCHIZOPHRENIA
Hoftman, G. D. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
BDNF gene methylation in brain of suicide subjects
Keller, S. (2009) · Università degli Studi di Napoli Federico II · doi:10.6092/unina/fedoa/3816
Mellios, N. (2009) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/pz41-4991
Self-citationTHE ROLE OF DENDRITIC BDNF TRANSCRIPTS ON ALTERED INHIBITORY CIRCUITRY IN AGING AND DEPRESSION
Oh, H. (2015) · D-Scholarship@Pitt (University of Pittsburgh)
The Hypoxic Rat Model for Obstetric Complications in Schizophrenia
Schmitt, A., Gebicke‐Haerter, P. J., Sommer, U. J., Heck, M., Lex, A., Herrera‐Marschitz, M., Zink, M., Fendt, M., & Falkai, P. (2011) · Neuromethods · doi:10.1007/978-1-61779-157-4_4
Immaturity of brain as an endophenotype of neuropsychiatric disorders
Hagihara, H., Shoji, H., & Miyakawa, T. (2016) · Folia Pharmacologica Japonica · doi:10.1254/fpj.148.168
Role of ErbB4 splicing in parvalbumin interneuron maturation and schizophrenia
Chung, D. W. (2016) · D-Scholarship@Pitt (University of Pittsburgh)
Inhibition of Gamma Oscillations in Healthy Subjects and Patients with Schizophrenia
Farzan, F. (2011) · TSpace (University of Toronto)
Transdiagnostic characterization of neuropsychiatric disorders by hyperexcitation-induced immaturityPreprint
Murano, T., Hagihara, H., Tajinda, K., Matsumoto, M., & Miyakawa, T. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/376962
Gattás, D. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2018.tde-06042018-140935
Xiang, W., & Na-Wang, L. (2019) · International Journal of Pain Management · doi:10.14302/issn.2688-5328.ijp-19-2731
SNPs associated with Schizophrenia: Evidence from Iranian patients
Molaei, A., Noormohammadi, Z., Salahshourifar, I., & Hezaveh, N. M. (2019) · Meta Gene · doi:10.1016/j.mgene.2019.100633
Salivary Biomarkers in Neurologic Diseases
Zian, Z., & Bouhoudan, A. (2020) · Springer eBooks · doi:10.1007/978-3-030-37681-9_7
Smith, S. E. (2020) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.7976
Sağlam, N. G. U., Düz, M. B., Yılmaz, S. S., Özen, M., & Balcıoğlu, İ. C. (2024) · Psychiatric Genetics · doi:10.1097/ypg.0000000000000371
Schmitt, A., Popovic, D., Raabe, F. J., Papiol, S., Martins‐de‐Souza, D., & Falkai, P. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_46
Purves-Tyson, T. D., Brown, A. M., Weissleder, C., Rothmond, D. A., & Shannon-Weickert, C. (2021) · Figshare · doi:10.6084/m9.figshare.14853387
Esuaikoh, V., Ibegbulam, S., Cook, A. J., McFarland, B., Nunnington, N., Perera, A., Feng, J., Cale, J. A., & King, M. V. (2026) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2026.1784522
Hernaez, M., Parellada, E., & Brunet, M. (2026) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2026.111709
Awathale, S. N., Chaudhari, A., Pardeshi, G. N., Popali, C., Goyal, S. N., & Nakhate, K. T. (2026) · Neuropeptides · doi:10.1016/j.npep.2026.102620
Murano, T. (n.d.) · Institutional Repositories DataBase (IRDB)
Graf, M., Ponserre, M., Sadeh, S., Robinson, J. W., Coy, M., Hunger, M., Lien, A., Ursu, D., Omrani, A., Magno, L., et al. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111182
Engel, M. (2014) · Research Online (University of Wollongong)
Metadata
- Authors
- Mellios, N., Huang, H.-S., Baker, S. P., Galdzicka, M., Ginns, E., & Akbarian, S.
- Affiliations
- University of Massachusetts Chan Medical School (US)
- Corresponding author
- Akbarian, Schahram
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 65
- Issue
- 12
- Pages
- 1006-1014
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W1979089999
- Cited by
- 266
- References
- 47
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 15 · 2023: 8 · 2022: 13 · 2021: 11 · 2020: 17 · 2019: 17 · 2018: 15 · 2017: 12 · 2016: 18 · 2015: 22 · 2014: 23 · 2013: 22 · 2012: 14
- FWCI
- 12.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Funders
- National Institute of Mental Health (R01MH081943, MH071476, MH081943, R01MH071476)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- schizophrenia, prefrontal cortex, neuropeptide Y, somatostatin, parvalbumin, brain-derived neurotrophic factor, miR-195, miR-30a-5p, microRNA regulation, antipsychotic drugs, BDNF knockout mice, postmortem brain
- MeSH terms
- Adult, Aged, Aged, 80 and over, Animals, Chromatin, gamma-Aminobutyric Acid, Gene Expression Regulation, Genotype, Humans, Immunoassay, Male, Mice, Inbred C57BL, Middle Aged, Neuropeptide Y, Parvalbumins, RNA, Schizophrenia, Somatostatin, Case-Control Studies, Prefrontal Cortex, Mice, Knockout, Brain-Derived Neurotrophic Factor, MicroRNAs, Immunoprecipitation, Mice, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
